EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval
Novavax Inc Annual Shareholders Meeting Transcript
Novavax (NVAX) Is Up 11.0% After New Pfizer Matrix-M License And Fresh Adjuvant Deals - Has The Bull Case Changed?
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model
Novavax (NASDAQ:NVAX) Given Buy Rating at BTIG Research - Daily Political
Critical Contrast: DNAPrint Genomics (OTCMKTS:DNAG) and Novavax (NASDAQ:NVAX) - Markets Daily
Novavax Pivots To Matrix M Licensing As Sanofi Takes Europe
Is Novavax (NVAX) Trading Near Fair Value As It Pivots Toward Royalties And Licensing?
Novavax (NASDAQ:NVAX) Trading Down 6.2% - Should You Sell? - Daily Political
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Novavax (NASDAQ:NVAX) Trading Down 7.3% - Here's Why - Stock Observer
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Zolmax
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Daily Political
Zacks Research Has Positive Outlook for Novavax Q2 Earnings - Stock Observer
